Call Us Today 1-800-322-5573 Search the Site
Our Building
Home
Mesothelioma
Practice Areas
Firm Overview
Partners
Associates
Verdicts & Cases
News & Resources
Contact Us
Mesothelioma Center
Asbestos Center
print this page
bookmark this page
e-mail this page
Practice Areas

Vioxx

Vioxx was voluntarily withdrawn from the market by its manufacturer, Merck, on September 30th, 2004. Vioxx is a non-steroidal anti-inflammatory drug (NSAID) prescribed most often for arthritis pain relief. Vioxx  was found to double or even triple the risk of heart attack and stroke. The risk was found during a study of more than 40,000 patients.

This was not the only study to show an increased risk of heart attack and stroke with Vioxx ; a prior study by Merck in June of 2000 first found these dangers.

The FDA expedited the approval of Vioxx in 1999 because of its expected value to arthritis and other pain sufferers. At the time of Vioxx's recall, nearly 7,000 unfavorable health problems resulting from it had been reported to the FDA.

Taken by 84 million people since 1999 and currently used by 2 million people worldwide, Vioxx was a $3 billion drug for Merck. It accounted for 12% of the company's revenue.

If you or a family member suffered a stroke, heart attack or kidney failure while taking Vioxx, the attorneys at Cooney and Conway will evaluate your potential lawsuit, and determine your best course of action.

 

For more information on Vioxx visit  - Vioxx Informational Pages

 

120 N Lasalle Street - Suite 3000 | Chicago, IL 60602-2415 | 1-800-322-5573 - FREE | 312-236-6166 - LOCAL | Email Us

Home | Mesothelioma | Practice Areas | Firm Overview | Partners | Associates | Verdicts & Cases | News & Resources | Contact Us
Mesothelioma Center | Asbestos Center

© 2008 Cooney & Conway. All rights reserved. Disclaimer | Site Map